spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Advertising
Simon Caplan

Editorial
Joseph O'Connor

We're also on Twitter! Follow us @PMPSmag  


     

 

Click here to view the digital version of PMPS

 


Click here to view the digital version of PMPS's Inhalation Technology Supplement 
 

pmps
 
 
Featured in this issue
Extractables and Leachables
The Landscape for Single-Use Systems

Jessica Shea at Merck 

Single-use systems hold great potential to reduce costs, start-up times, and improve E&L risk evaluation.
Inhalation Technology Supplement
Spotlight: Dose Counters and Indicators A Real Patient Need

H&T Presspart showcases its fully embedded and connected metered-dose inhaler eMDITM, which aims to improve patient adherence.
  Extractables and Leachables
Transdermal Delivery Systems

Dr Wayland Rushing at Eurofins

Many problems arise from the increased popularity of transdermal delivery systems, but new FDA guidance may help offset these.

spacer


Published quarterly in
February, May,
August, and November


 

Industry Events

World Vaccine Congress Washington

7-9 April 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
News and Press Releases

3P Biopharmaceuticals receives FDA approval

[Pamplona, September 16th, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organisation (CDMO) specialized in process development and GMP manufacturing of biologics, receives FDA approval after completing the Pre-Approval Inspection (PAI) conducted at the 3P drug substance manufacturing facility.
More info >>

 
White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies

NanoSight

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement